Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Implantable Cardioverter Defibrillator (ICD) market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market is expected to play significant role in the development of demand and improvement due to COVID-19..
Based on the type of product, the global Implantable Cardioverter Defibrillator (ICD) market segmented into
By Products Type
Single Chamber ICD
Dual Chamber ICD
Biventricular ICD
By Implantation Site
Transvenous ICD
Subcutaneous ICD
Based on the end-use, the global Implantable Cardioverter Defibrillator (ICD) market classified into
Bradycardia
Tachycardia
Heart Failure
Others
Based on geography, the global Implantable Cardioverter Defibrillator (ICD) market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Medtronic
St. Jude Medical
Boston Scientific
Philips Healthcare
Zoll Medical
Biotronik Se
Physio-Control International
Cardiac Science
Sorin Group
Nihon Kohden
Shree Pacetronix Ltd.
EBR Systems
MEDICO S.p.A.
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) INDUSTRY
2.1 Summary about Implantable Cardioverter Defibrillator (ICD) Industry
2.2 Implantable Cardioverter Defibrillator (ICD) Market Trends
2.2.1 Implantable Cardioverter Defibrillator (ICD) Production & Consumption Trends
2.2.2 Implantable Cardioverter Defibrillator (ICD) Demand Structure Trends
2.3 Implantable Cardioverter Defibrillator (ICD) Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 By Products Type
4.2.2 Single Chamber ICD
4.2.3 Dual Chamber ICD
4.2.4 Biventricular ICD
4.2.5 By Implantation Site
4.2.6 Transvenous ICD
4.2.7 Subcutaneous ICD
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Bradycardia
4.3.2 Tachycardia
4.3.3 Heart Failure
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 By Products Type
5.2.2 Single Chamber ICD
5.2.3 Dual Chamber ICD
5.2.4 Biventricular ICD
5.2.5 By Implantation Site
5.2.6 Transvenous ICD
5.2.7 Subcutaneous ICD
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Bradycardia
5.3.2 Tachycardia
5.3.3 Heart Failure
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 By Products Type
6.2.2 Single Chamber ICD
6.2.3 Dual Chamber ICD
6.2.4 Biventricular ICD
6.2.5 By Implantation Site
6.2.6 Transvenous ICD
6.2.7 Subcutaneous ICD
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Bradycardia
6.3.2 Tachycardia
6.3.3 Heart Failure
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 By Products Type
7.2.2 Single Chamber ICD
7.2.3 Dual Chamber ICD
7.2.4 Biventricular ICD
7.2.5 By Implantation Site
7.2.6 Transvenous ICD
7.2.7 Subcutaneous ICD
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Bradycardia
7.3.2 Tachycardia
7.3.3 Heart Failure
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 By Products Type
8.2.2 Single Chamber ICD
8.2.3 Dual Chamber ICD
8.2.4 Biventricular ICD
8.2.5 By Implantation Site
8.2.6 Transvenous ICD
8.2.7 Subcutaneous ICD
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Bradycardia
8.3.2 Tachycardia
8.3.3 Heart Failure
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 By Products Type
9.2.2 Single Chamber ICD
9.2.3 Dual Chamber ICD
9.2.4 Biventricular ICD
9.2.5 By Implantation Site
9.2.6 Transvenous ICD
9.2.7 Subcutaneous ICD
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Bradycardia
9.3.2 Tachycardia
9.3.3 Heart Failure
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Medtronic
10.1.2 St. Jude Medical
10.1.3 Boston Scientific
10.1.4 Philips Healthcare
10.1.5 Zoll Medical
10.1.6 Biotronik Se
10.1.7 Physio-Control International
10.1.8 Cardiac Science
10.1.9 Sorin Group
10.1.10 Nihon Kohden
10.1.11 Shree Pacetronix Ltd.
10.1.12 EBR Systems
10.1.13 MEDICO S.p.A.
10.2 Implantable Cardioverter Defibrillator (ICD) Sales Date of Major Players (2017-2020e)
10.2.1 Medtronic
10.2.2 St. Jude Medical
10.2.3 Boston Scientific
10.2.4 Philips Healthcare
10.2.5 Zoll Medical
10.2.6 Biotronik Se
10.2.7 Physio-Control International
10.2.8 Cardiac Science
10.2.9 Sorin Group
10.2.10 Nihon Kohden
10.2.11 Shree Pacetronix Ltd.
10.2.12 EBR Systems
10.2.13 MEDICO S.p.A.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
1.Table Implantable Cardioverter Defibrillator (ICD) Product Type Overview
2.Table Implantable Cardioverter Defibrillator (ICD) Product Type Market Share List
3.Table Implantable Cardioverter Defibrillator (ICD) Product Type of Major Players
4.Table Brief Introduction of Medtronic
5.Table Brief Introduction of St. Jude Medical
6.Table Brief Introduction of Boston Scientific
7.Table Brief Introduction of Philips Healthcare
8.Table Brief Introduction of Zoll Medical
9.Table Brief Introduction of Biotronik Se
10.Table Brief Introduction of Physio-Control International
11.Table Brief Introduction of Cardiac Science
12.Table Brief Introduction of Sorin Group
13.Table Brief Introduction of Nihon Kohden
14.Table Brief Introduction of Shree Pacetronix Ltd.
15.Table Brief Introduction of EBR Systems
16.Table Brief Introduction of MEDICO S.p.A.
17.Table Products & Services of Medtronic
18.Table Products & Services of St. Jude Medical
19.Table Products & Services of Boston Scientific
20.Table Products & Services of Philips Healthcare
21.Table Products & Services of Zoll Medical
22.Table Products & Services of Biotronik Se
23.Table Products & Services of Physio-Control International
24.Table Products & Services of Cardiac Science
25.Table Products & Services of Sorin Group
26.Table Products & Services of Nihon Kohden
27.Table Products & Services of Shree Pacetronix Ltd.
28.Table Products & Services of EBR Systems
29.Table Products & Services of MEDICO S.p.A.
30.Table Market Distribution of Major Players
31.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
32.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
33.Table Global Implantable Cardioverter Defibrillator (ICD) Market Forecast (Million USD) by Region 2021f-2026f
34.Table Global Implantable Cardioverter Defibrillator (ICD) Market Forecast (Million USD) Share by Region 2021f-2026f
35.Table Global Implantable Cardioverter Defibrillator (ICD) Market Forecast (Million USD) by Demand 2021f-2026f
36.Table Global Implantable Cardioverter Defibrillator (ICD) Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Implantable Cardioverter Defibrillator (ICD) Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Implantable Cardioverter Defibrillator (ICD) Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Implantable Cardioverter Defibrillator (ICD) Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Implantable Cardioverter Defibrillator (ICD) Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Implantable Cardioverter Defibrillator (ICD) Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Implantable Cardioverter Defibrillator (ICD) Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Implantable Cardioverter Defibrillator (ICD) Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure By Products Type Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Single Chamber ICD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Dual Chamber ICD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Biventricular ICD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure By Implantation Site Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Transvenous ICD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Subcutaneous ICD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Bradycardia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Tachycardia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Heart Failure Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure By Products Type Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Single Chamber ICD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Dual Chamber ICD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Biventricular ICD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure By Implantation Site Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Transvenous ICD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Subcutaneous ICD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Bradycardia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Tachycardia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Heart Failure Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure By Products Type Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Single Chamber ICD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Dual Chamber ICD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Biventricular ICD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure By Implantation Site Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Transvenous ICD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Subcutaneous ICD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Bradycardia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Tachycardia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Heart Failure Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure By Products Type Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Single Chamber ICD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Dual Chamber ICD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Biventricular ICD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure By Implantation Site Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Transvenous ICD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Subcutaneous ICD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Bradycardia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Tachycardia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Heart Failure Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure Brazil